Apeiron Investment Group Ltd. - 01 Jul 2024 Form 3 Insider Report for BIONOMICS LTD/ADR

Role
10%+ Owner
Signature
Apeiron Investment Group Ltd. By: /s/ Mario Frendo, Director
Issuer symbol
N/A
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
3
Filing time
07 Oct 2024, 18:17:04 UTC
Previous filing
17 Apr 2024
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BNOX Ordinary Shares 183,121,441 01 Jul 2024 By Apeiron Investment Group Ltd. F1, F2
holding BNOX Ordinary Shares 93,369,060 01 Jul 2024 By Apeiron Presight Capital Fund II, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes Ordinary Shares represented by American Depositary Shares.
F2 The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.
F3 The reportable securities are held by Apeiron Presight Capital Fund II, L.P. ("Apeiron Presight"). Apeiron and Fabian Hansen are the managing members of Presight Capital Management I, L.L.C. ("Presight Management"), which is the general partner of Apeiron Presight. As a result, each of Apeiron, Mr. Hansen and Presight Management may be deemed to share beneficial ownership of the securities.

Remarks:

The Reporting Persons were unaware that the Issuer ceased to be a foreign private issuer as of July 1, 2024, resulting in this delinquent report on Form 3.